Introducing an automated high content confocal imaging approach for Organs-on-Chips

Samantha Peel, Adam M Corrigan, Beate Ehrhardt, Kyung-Jin Jang, Pedro Caetano-Pinto, Matthew Boeckeler, Jonathan E Rubins, Konstantia Kodella, Debora B Petropolis, Janey Ronxhi, Gauri Kulkarni, Alison J Foster, Dominic Williams, Geraldine A Hamilton, Lorna Ewart

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Organ-Chips are micro-engineered systems that aim to recapitulate the organ microenvironment. Implementation of Organ-Chips within the pharmaceutical industry aims to improve the probability of success of drugs reaching late stage clinical trial by generating models for drug discovery that are of human origin and have disease relevance. We are adopting the use of Organ-Chips for enhancing pre-clinical efficacy and toxicity evaluation and prediction. Whilst capturing cellular phenotype via imaging in response to drug exposure is a useful readout in these models, application has been limited due to difficulties in imaging the chips at scale. Here we created an end-to-end, automated workflow to capture and analyse confocal images of multicellular Organ-Chips to assess detailed cellular phenotype across large batches of chips. By automating this process, we not only reduced acquisition time, but we also minimised process variability and user bias. This enabled us to establish, for the first time, a framework of statistical best practice for Organ-Chip imaging, creating the capability of using Organ-Chips and imaging for routine testing in drug discovery applications that rely on quantitative image data for decision making. We tested our approach using benzbromarone, whose mechanism of toxicity has been linked to mitochondrial damage with subsequent induction of apoptosis and necrosis, and staurosporine, a tool inducer of apoptosis. We also applied this workflow to assess the hepatotoxic effect of an active AstraZeneca drug candidate illustrating its applicability in drug safety assessment beyond testing tool compounds. Finally, we have demonstrated that this approach could be adapted to Organ-Chips of different shapes and sizes through application to a Kidney-Chip.

Original languageEnglish
Pages (from-to)410-421
Number of pages12
JournalLab on a Chip
Volume19
Issue number3
Early online date21 Jan 2019
DOIs
Publication statusPublished - 29 Jan 2019

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Chemistry(all)
  • Biomedical Engineering

Cite this

Peel, S., Corrigan, A. M., Ehrhardt, B., Jang, K-J., Caetano-Pinto, P., Boeckeler, M., ... Ewart, L. (2019). Introducing an automated high content confocal imaging approach for Organs-on-Chips. Lab on a Chip, 19(3), 410-421. https://doi.org/10.1039/c8lc00829a

Introducing an automated high content confocal imaging approach for Organs-on-Chips. / Peel, Samantha; Corrigan, Adam M; Ehrhardt, Beate; Jang, Kyung-Jin; Caetano-Pinto, Pedro; Boeckeler, Matthew; Rubins, Jonathan E; Kodella, Konstantia; Petropolis, Debora B; Ronxhi, Janey; Kulkarni, Gauri; Foster, Alison J; Williams, Dominic; Hamilton, Geraldine A; Ewart, Lorna.

In: Lab on a Chip, Vol. 19, No. 3, 29.01.2019, p. 410-421.

Research output: Contribution to journalArticle

Peel, S, Corrigan, AM, Ehrhardt, B, Jang, K-J, Caetano-Pinto, P, Boeckeler, M, Rubins, JE, Kodella, K, Petropolis, DB, Ronxhi, J, Kulkarni, G, Foster, AJ, Williams, D, Hamilton, GA & Ewart, L 2019, 'Introducing an automated high content confocal imaging approach for Organs-on-Chips', Lab on a Chip, vol. 19, no. 3, pp. 410-421. https://doi.org/10.1039/c8lc00829a
Peel S, Corrigan AM, Ehrhardt B, Jang K-J, Caetano-Pinto P, Boeckeler M et al. Introducing an automated high content confocal imaging approach for Organs-on-Chips. Lab on a Chip. 2019 Jan 29;19(3):410-421. https://doi.org/10.1039/c8lc00829a
Peel, Samantha ; Corrigan, Adam M ; Ehrhardt, Beate ; Jang, Kyung-Jin ; Caetano-Pinto, Pedro ; Boeckeler, Matthew ; Rubins, Jonathan E ; Kodella, Konstantia ; Petropolis, Debora B ; Ronxhi, Janey ; Kulkarni, Gauri ; Foster, Alison J ; Williams, Dominic ; Hamilton, Geraldine A ; Ewart, Lorna. / Introducing an automated high content confocal imaging approach for Organs-on-Chips. In: Lab on a Chip. 2019 ; Vol. 19, No. 3. pp. 410-421.
@article{7532dcf1ae3a4aa2a539c04680e0ac98,
title = "Introducing an automated high content confocal imaging approach for Organs-on-Chips",
abstract = "Organ-Chips are micro-engineered systems that aim to recapitulate the organ microenvironment. Implementation of Organ-Chips within the pharmaceutical industry aims to improve the probability of success of drugs reaching late stage clinical trial by generating models for drug discovery that are of human origin and have disease relevance. We are adopting the use of Organ-Chips for enhancing pre-clinical efficacy and toxicity evaluation and prediction. Whilst capturing cellular phenotype via imaging in response to drug exposure is a useful readout in these models, application has been limited due to difficulties in imaging the chips at scale. Here we created an end-to-end, automated workflow to capture and analyse confocal images of multicellular Organ-Chips to assess detailed cellular phenotype across large batches of chips. By automating this process, we not only reduced acquisition time, but we also minimised process variability and user bias. This enabled us to establish, for the first time, a framework of statistical best practice for Organ-Chip imaging, creating the capability of using Organ-Chips and imaging for routine testing in drug discovery applications that rely on quantitative image data for decision making. We tested our approach using benzbromarone, whose mechanism of toxicity has been linked to mitochondrial damage with subsequent induction of apoptosis and necrosis, and staurosporine, a tool inducer of apoptosis. We also applied this workflow to assess the hepatotoxic effect of an active AstraZeneca drug candidate illustrating its applicability in drug safety assessment beyond testing tool compounds. Finally, we have demonstrated that this approach could be adapted to Organ-Chips of different shapes and sizes through application to a Kidney-Chip.",
author = "Samantha Peel and Corrigan, {Adam M} and Beate Ehrhardt and Kyung-Jin Jang and Pedro Caetano-Pinto and Matthew Boeckeler and Rubins, {Jonathan E} and Konstantia Kodella and Petropolis, {Debora B} and Janey Ronxhi and Gauri Kulkarni and Foster, {Alison J} and Dominic Williams and Hamilton, {Geraldine A} and Lorna Ewart",
year = "2019",
month = "1",
day = "29",
doi = "10.1039/c8lc00829a",
language = "English",
volume = "19",
pages = "410--421",
journal = "Lab on a Chip",
issn = "1473-0197",
publisher = "Royal Society of Chemistry",
number = "3",

}

TY - JOUR

T1 - Introducing an automated high content confocal imaging approach for Organs-on-Chips

AU - Peel, Samantha

AU - Corrigan, Adam M

AU - Ehrhardt, Beate

AU - Jang, Kyung-Jin

AU - Caetano-Pinto, Pedro

AU - Boeckeler, Matthew

AU - Rubins, Jonathan E

AU - Kodella, Konstantia

AU - Petropolis, Debora B

AU - Ronxhi, Janey

AU - Kulkarni, Gauri

AU - Foster, Alison J

AU - Williams, Dominic

AU - Hamilton, Geraldine A

AU - Ewart, Lorna

PY - 2019/1/29

Y1 - 2019/1/29

N2 - Organ-Chips are micro-engineered systems that aim to recapitulate the organ microenvironment. Implementation of Organ-Chips within the pharmaceutical industry aims to improve the probability of success of drugs reaching late stage clinical trial by generating models for drug discovery that are of human origin and have disease relevance. We are adopting the use of Organ-Chips for enhancing pre-clinical efficacy and toxicity evaluation and prediction. Whilst capturing cellular phenotype via imaging in response to drug exposure is a useful readout in these models, application has been limited due to difficulties in imaging the chips at scale. Here we created an end-to-end, automated workflow to capture and analyse confocal images of multicellular Organ-Chips to assess detailed cellular phenotype across large batches of chips. By automating this process, we not only reduced acquisition time, but we also minimised process variability and user bias. This enabled us to establish, for the first time, a framework of statistical best practice for Organ-Chip imaging, creating the capability of using Organ-Chips and imaging for routine testing in drug discovery applications that rely on quantitative image data for decision making. We tested our approach using benzbromarone, whose mechanism of toxicity has been linked to mitochondrial damage with subsequent induction of apoptosis and necrosis, and staurosporine, a tool inducer of apoptosis. We also applied this workflow to assess the hepatotoxic effect of an active AstraZeneca drug candidate illustrating its applicability in drug safety assessment beyond testing tool compounds. Finally, we have demonstrated that this approach could be adapted to Organ-Chips of different shapes and sizes through application to a Kidney-Chip.

AB - Organ-Chips are micro-engineered systems that aim to recapitulate the organ microenvironment. Implementation of Organ-Chips within the pharmaceutical industry aims to improve the probability of success of drugs reaching late stage clinical trial by generating models for drug discovery that are of human origin and have disease relevance. We are adopting the use of Organ-Chips for enhancing pre-clinical efficacy and toxicity evaluation and prediction. Whilst capturing cellular phenotype via imaging in response to drug exposure is a useful readout in these models, application has been limited due to difficulties in imaging the chips at scale. Here we created an end-to-end, automated workflow to capture and analyse confocal images of multicellular Organ-Chips to assess detailed cellular phenotype across large batches of chips. By automating this process, we not only reduced acquisition time, but we also minimised process variability and user bias. This enabled us to establish, for the first time, a framework of statistical best practice for Organ-Chip imaging, creating the capability of using Organ-Chips and imaging for routine testing in drug discovery applications that rely on quantitative image data for decision making. We tested our approach using benzbromarone, whose mechanism of toxicity has been linked to mitochondrial damage with subsequent induction of apoptosis and necrosis, and staurosporine, a tool inducer of apoptosis. We also applied this workflow to assess the hepatotoxic effect of an active AstraZeneca drug candidate illustrating its applicability in drug safety assessment beyond testing tool compounds. Finally, we have demonstrated that this approach could be adapted to Organ-Chips of different shapes and sizes through application to a Kidney-Chip.

UR - http://www.scopus.com/inward/record.url?scp=85060599044&partnerID=8YFLogxK

U2 - 10.1039/c8lc00829a

DO - 10.1039/c8lc00829a

M3 - Article

VL - 19

SP - 410

EP - 421

JO - Lab on a Chip

JF - Lab on a Chip

SN - 1473-0197

IS - 3

ER -